Target intelligence / Profile preview

3-keto-L-gulonate 6-phosphate decarboxylase (UlaD)

Target
UlaD
Molecular classification
Enzyme, Lyase, Carboxy-lyase
01

Overview

3-keto-L-gulonate 6-phosphate decarboxylase (UlaD) is a bacterial enzyme that plays a critical role in the anaerobic catabolism of L-ascorbate (Vitamin C) [UniProt]. It catalyzes the conversion of 3-keto-L-gulonate 6-phosphate into L-xylulose 5-phosphate and carbon dioxide, a reaction that allows bacteria to utilize ascorbate as a carbon and energy source under oxygen-limited conditions [PubMed]. The enzyme is a member of the orotidine 5'-monophosphate decarboxylase (OMPDC) suprafamily and requires divalent metal ions, such as magnesium or manganese, for its catalytic function [PubMed]. While it is found in various enteric bacteria like Escherichia coli, the entire L-ascorbate utilization pathway is absent in humans, making the enzyme a potential target for narrow-spectrum antimicrobials [Journal of Biological Chemistry]. Such inhibitors could theoretically disrupt the fitness of pathogenic bacteria in the human gut without affecting host metabolism [Journal of Bacteriology]. Currently, there are no approved drugs or clinical-stage compounds that target this enzyme, and it remains primarily a subject of research in microbial biochemistry and structural biology [PubMed].

Other names
UlaD3-oxo-L-gulonate 6-phosphate decarboxylaseSgbDKGPDCL-ascorbate-6-phosphate catabolism protein D
02

Mechanism of action

No known therapeutic drugs; the enzyme naturally catalyzes the decarboxylation of 3-keto-L-gulonate 6-phosphate to L-xylulose 5-phosphate.

03

Biological functions

L-ascorbate catabolismCarbohydrate metabolismAnaerobic metabolism
04

Disease associations

Infection
05

Safety considerations

Potential for off-target effects on other OMPDC suprafamily membersMinimal human toxicity expected due to the absence of the L-ascorbate catabolic pathway in humans

Beyond the preview

Go deeper on 3-keto-L-gulonate 6-phosphate decarboxylase (UlaD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-keto-L-gulonate 6-phosphate decarboxylase (UlaD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call